Abstract | OBJECTIVE: To examine prescription Food and Drug Administration (FDA) C, D and X drugs in general obstetric population. STUDY DESIGN: Historical cohort study. RESULT: A total of 18 575 women who gave a birth in Saskatchewan between January 1997 and December 2000 were included. Among them, 3604 (19.4%) received FDA C, D or X drugs at least once during pregnancy. The pregnancy exposure rates were 15.8, 5.2 and 3.9%, respectively, for category C, D and X drugs, and were 11.2, 7.3 and 8.2%, respectively, in the first, second and third trimesters. Salbutamol ( albuterol), trimethoprim/sulfamethoxazole ( co-trimoxazole), ibuprofen, naproxen and oral contraceptives were the most common C, D, X drugs used during pregnancy. CONCLUSION:
|
Authors | S W Wen, T Yang, D Krewski, Q Yang, C Nimrod, P Garner, W Fraser, O Olatunbosun, M C Walker |
Journal | Journal of perinatology : official journal of the California Perinatal Association
(J Perinatol)
Vol. 28
Issue 5
Pg. 324-9
(May 2008)
ISSN: 0743-8346 [Print] United States |
PMID | 18288118
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Contraceptives, Oral
- Naproxen
- Trimethoprim, Sulfamethoxazole Drug Combination
- Albuterol
- Ibuprofen
|
Topics |
- Adult
- Albuterol
(administration & dosage, adverse effects)
- Contraceptives, Oral
(administration & dosage)
- Cross-Sectional Studies
- Drug Prescriptions
- Drug-Related Side Effects and Adverse Reactions
- Female
- Gestational Age
- Humans
- Ibuprofen
(administration & dosage, adverse effects)
- Infant, Newborn
- Naproxen
(administration & dosage, adverse effects)
- Population Surveillance
- Pregnancy
- Prenatal Exposure Delayed Effects
(chemically induced, epidemiology)
- Saskatchewan
- Trimethoprim, Sulfamethoxazole Drug Combination
(administration & dosage, adverse effects)
- United States
- United States Food and Drug Administration
|